Sign up to save your podcasts
Or
Share EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD
We discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.
View all episodes
By Retina Synthesis
4.5
88 ratings
We discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.
More shows like Retina Synthesis
View all
New Retina Radio by Eyetube
18 Listeners
White Coat Investor Podcast
2,445 Listeners
The Daily
112,683 Listeners
WSJ Minute Briefing
670 Listeners
Up First from NPR
56,469 Listeners
Bogleheads On Investing Podcast
595 Listeners
MedEdTalks - Ophthalmology
4 Listeners
American Journal of Ophthalmology Podcasts Collection
11 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
18 Listeners
Talking Euretina
1 Listeners
RetinaRounds™
0 Listeners
The Last Invention
708 Listeners